Delivery Order SPE2DB20D1050-SPE2DB25FH93K
- Not listed
- The Defense Logistics Agency awarded a $10,479 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 24, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.80 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, awarded on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a firm fixed price procurement with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a $16,766.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with performance at the contractor's Conshohocken, Pennsylvania facility. The order, issued September 16, 2025, with completion targeted for September 17, 2025, represents a competitive award with no set-aside designation. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,226.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of August 12, 2025. The award was made on August 11, 2025, with no set-aside designation, and performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $8,764.19 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price contract, issued on July 24, 2025, represents a competitively awarded non-set-aside transaction with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $18,728.13. The order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued...
- The Defense Logistics Agency awarded a $20,958 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 24, 2025. This non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,900.43 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This competitively awarded, firm fixed-price contract was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child delivery order, this award falls under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $9,640.68 to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents. The contract, awarded on May 27, 2025, with an ultimate completion date of May 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH93KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $23,443.63 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, awarded on September 23, 2025, with a completion date of September 24, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee, and the place of performance is also listed as Conshohocken. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an expansive $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a broad portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare needs. The rabies vaccine delivery under this order supports critical medical readiness requirements across the Defense Health Agency and other federal healthcare systems. The company's federal contracting history demonstrates consistent success in competitively awarded, non-set-aside pharmaceutical delivery orders through the DLA Medical Supply Chain, positioning it as a key strategic vendor for federal vaccine and pharmaceutical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 9/23/25 |